INDIANAPOLIS, April 18, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has introduced a new Electronic Medical Record (EMR) interface for the U.S. Department of Veterans Affairs (VA) that helps VA healthcare facilities improve their efficiency and accuracy by transmitting patient diabetes management data directly into the VistA computerized patient record system (CPRS).
The new JResultNet™ middleware module from Dawning Technologies Inc. enables VA providers to transfer patient blood glucose test results automatically and securely to their EMR from the ACCU-CHEK® 360 Diabetes Management System, a tool designed to help physicians and patients manage diabetes in an outpatient setting. Dawning is a leading supplier of connectivity solutions to the clinical laboratory market.
"This integration package allows any provider within the VA's healthcare system to access a patient's glucose test results, and it offers them a much easier, more accurate way to capture the information and deliver it to the patient's EMR," said Keith Snyder, director of marketing at Roche Diagnostics Corporation. "It has already been successfully implemented at several VA sites, and is contributing to improved efficiency levels."
The JResultNet middleware module delivers test results from the ACCU-CHEK 360 system to the VistA system as an HL7-based TIU (text integration utility) connection – a standard component of the VistA system. The enhanced connectivity helps reduce the potential for errors and helps increase workflow efficiency for the healthcare provider.
About Diabetes and the VADiabetes impacts over 20 percent of VA patients, representing more than 1 million veterans at any given time, and that number continues to rise. The cost of treating complications from diabetes is significant, with one diabetes-related heart attack estimated to cost over $14,000. The VA's diabetes programs are focused on reduc
|SOURCE Roche Diagnostics|
Copyright©2010 PR Newswire.
All rights reserved